Short-term risk of disease progression in HIV-1 infected children receiving no antiretroviral therapy or zidovudine monotherapy: estimates according to CD4 percent, viral load, and age.

19 Apr, 2003

Authors: HIV Paediatric Prognostic Markers Collaborative Study Group.

Published in: Lancet 2003; 362:1605-11.